Inventor · disambiguated record
Chuan-Chu Chou
Also filed as: CHOU CHUAN-CHU
20 granted patents·7 pending applications·221 citations·filing 1993–2023
94Inventor score
Files withNANJING LEGEND BIOTECH CO LTD13SCHERING CORP8LEGEND BIOTECH USA INC2SHANGHAI QILU PHARMACEUTICAL RES AND DEVELOPMENT CENTRE LTD2CHOU CHUAN-CHU1
Top patents by PatentIndex Score
27 records- 0194US10934363B2Chimeric antigen receptors based on single domain antibodies and methods of use thereofLEGEND BIOTECH USA INC·Filed 2016·Granted Mar 2, 2021·24 cites·24 claims
- 0290US6451982B1Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5SCHERING CORP·Filed 2000·Granted Sep 17, 2002·35 cites·17 claims
- 0386US8282914B2Method for treating atherosclerosis by administering human MCP1 fusionsCHOU CHUAN-CHU·Filed 2011·Granted Oct 9, 2012·16 cites·7 claims
- 0486US5789192AMammalian receptors for interleukin-10 (IL-10)SCHERING CORP·Filed 1993·Granted Aug 4, 1998·45 cites·21 claims
- 0585US8524217B2MCP1-Ig fusion variantsPRESTA LEONARD G·Filed 2011·Granted Sep 3, 2013·8 cites·10 claims
- 0684US11673954B2Single-domain antibodies and variants thereof against PD-L1NANJING LEGEND BIOTECH CO LTD·Filed 2018·Granted Jun 13, 2023·3 cites·19 claims
- 0783US11447573B2Multispecific antigen binding proteins and methods of use thereofNANJING LEGEND BIOTECH CO LTD·Filed 2017·Granted Sep 20, 2022·3 cites·19 claims
- 0881US6056957AHumanized monoclonal antibodies against human interleukin-5SCHERING CORP·Filed 1994·Granted May 2, 2000·48 cites·30 claims
- 0979US11905327B2Single-domain antibodies and variants thereof against TIGITNANJING LEGEND BIOTECH CO LTD·Filed 2018·Granted Feb 20, 2024·1 cites·18 claims
- 1079US11472881B2Single-domain antibodies and variants thereof against CTLA-4NANJING LEGEND BIOTECH CO LTD·Filed 2017·Granted Oct 18, 2022·2 cites·21 claims
- 1179US5863796AAntibodies which specifically bind mammalian receptors for interleukin-10 (IL-10)SCHERING CORP·Filed 1995·Granted Jan 26, 1999·24 cites·25 claims
- 1275US11958903B2Single-domain antibodies against LAG-3 and uses thereofNANJING LEGEND BIOTECH CO LTD·Filed 2019·Granted Apr 16, 2024·1 cites·23 claims
- 1374US12168688B2Antibodies and variants thereof against PD-L1NANJING LEGEND BIOTECH CO LTD·Filed 2018·Granted Dec 17, 2024·1 cites·21 claims
- 1474US2024124580A1Single-domain antibodies and variants thereof against tigitNANJING LEGEND BIOTECH CO LTD·Filed 2023·Application pending·0 cites
- 1573US7972591B2Methods for treating rheumatoid arthritis and multiple sclerosis using MCP1 fusionsSCHERING CORP·Filed 2009·Granted Jul 5, 2011·1 cites·22 claims
- 1672US7713521B2MCP1 fusionsSCHERING CORP·Filed 2006·Granted May 11, 2010·1 cites·8 claims
- 1766US2023059836A1Multispecific antigen binding proteins and methods of use thereofNANJING LEGEND BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 1859US2021261675A1Chimeric antigen receptors based on single-domain antibodies and methods of use thereofLEGEND BIOTECH USA INC·Filed 2021·Application pending·0 cites
- 1955US2024239878A1Binding molecule against dll3 and use thereofSHANGHAI QILU PHARMACEUTICAL RES AND DEVELOPMENT CENTRE LTD·Filed 2022·Application pending·0 cites
- 2053US2024010748A1Bispecific antibody for claudin 18a2 and cd3 and application of bispecific antibodySHANGHAI QILU PHARMACEUTICAL RES AND DEVELOPMENT CENTRE LTD·Filed 2021·Application pending·0 cites
- 2150US11713353B2Single-domain antibodies and variants thereof against PD-1NANJING LEGEND BIOTECH CO LTD·Filed 2019·Granted Aug 1, 2023·0 cites·16 claims
- 2249US11505601B2Compositions and methods using a single-domain antibody binding transferrin and protein A for increasing protein half-life in serumNANJING LEGEND BIOTECH CO LTD·Filed 2017·Granted Nov 22, 2022·0 cites·14 claims
- 2347US2021070855A1Anti-cd47 antibodies that do not cause significant red blood cell agllutinationNANJING LEGEND BIOTECH CO LTD·Filed 2019·Application pending·0 cites
- 2446US5985828AMammalian receptors for interleukin-10 (IL-10)SCHERING CORP·Filed 1995·Granted Nov 16, 1999·6 cites·23 claims
- 2545US2020369770A1Multispecific antigen binding proteins and methods of use thereofNANJING LEGEND BIOTECH CO LTD·Filed 2019·Application pending·0 cites
- 2643US11708410B2Antibodies and variants thereof against TIGITNANJING LEGEND BIOTECH CO LTD·Filed 2019·Granted Jul 25, 2023·0 cites·23 claims
- 2739US6423500B1Mammalian receptors for interleukin-10SCHERING CORP·Filed 1999·Granted Jul 23, 2002·2 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Chuan-Chu Chou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →